TR199901857T2 - Yeni 2-amino-ikameli piridinler - Google Patents

Yeni 2-amino-ikameli piridinler

Info

Publication number
TR199901857T2
TR199901857T2 TR1999/01857T TR9901857T TR199901857T2 TR 199901857 T2 TR199901857 T2 TR 199901857T2 TR 1999/01857 T TR1999/01857 T TR 1999/01857T TR 9901857 T TR9901857 T TR 9901857T TR 199901857 T2 TR199901857 T2 TR 199901857T2
Authority
TR
Turkey
Prior art keywords
amino
substituted pyridines
new
hydroxides
deshydroxy
Prior art date
Application number
TR1999/01857T
Other languages
English (en)
Turkish (tr)
Inventor
Schmeck Carsten
Brandes Arndt
Lgers Michael
Schmidt Gunter
Bremm Klaus-Dieter
Bischoff Hilmar
Schmidt Delf
Schuhmacher Joachim
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR199901857T2 publication Critical patent/TR199901857T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
TR1999/01857T 1997-02-05 1998-01-23 Yeni 2-amino-ikameli piridinler TR199901857T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19704243A DE19704243A1 (de) 1997-02-05 1997-02-05 Neue 2-Amino-substituierte Pyridine

Publications (1)

Publication Number Publication Date
TR199901857T2 true TR199901857T2 (xx) 1999-10-21

Family

ID=7819326

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01857T TR199901857T2 (xx) 1997-02-05 1998-01-23 Yeni 2-amino-ikameli piridinler

Country Status (19)

Country Link
EP (1) EP0973744A1 (no)
JP (1) JP2001510478A (no)
KR (1) KR20000070756A (no)
CN (1) CN1252057A (no)
AU (1) AU730109B2 (no)
BG (1) BG103631A (no)
BR (1) BR9807181A (no)
CA (1) CA2279636A1 (no)
CZ (1) CZ279299A3 (no)
DE (1) DE19704243A1 (no)
HU (1) HUP0001022A2 (no)
ID (1) ID24208A (no)
IL (1) IL131127A0 (no)
NO (1) NO993738L (no)
NZ (1) NZ337011A (no)
PL (1) PL334899A1 (no)
SK (1) SK104099A3 (no)
TR (1) TR199901857T2 (no)
WO (1) WO1998034920A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
JP4547148B2 (ja) 2001-06-22 2010-09-22 ベンド・リサーチ・インコーポレーテッド 非晶質薬剤の吸着物の医薬組成物
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
WO2003063833A1 (en) 2002-02-01 2003-08-07 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
AU2004222436A1 (en) 2003-03-17 2004-09-30 Japan Tobacco Inc. Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
MXPA06001417A (es) 2003-08-04 2006-05-15 Pfizer Prod Inc Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas.
RU2330682C2 (ru) 2003-09-26 2008-08-10 Джапан Тобакко Инк. Способ ингибирования продуцирования остаточных липопротеинов
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006032987A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Indoline compounds and their use in the treatment of arteriosclerosis
EP2548894A1 (en) 2005-02-03 2013-01-23 Bend Research, Inc. Pharmaceutical compositions with enhanced performance
US20100113473A1 (en) 2008-10-30 2010-05-06 Player Mark R Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis

Also Published As

Publication number Publication date
JP2001510478A (ja) 2001-07-31
KR20000070756A (ko) 2000-11-25
NO993738L (no) 1999-09-17
NO993738D0 (no) 1999-08-02
ID24208A (id) 2000-07-13
AU730109B2 (en) 2001-02-22
NZ337011A (en) 2001-04-27
AU6212398A (en) 1998-08-26
CN1252057A (zh) 2000-05-03
EP0973744A1 (de) 2000-01-26
WO1998034920A1 (de) 1998-08-13
CA2279636A1 (en) 1998-08-13
DE19704243A1 (de) 1998-08-06
PL334899A1 (en) 2000-03-27
HUP0001022A2 (hu) 2000-09-28
SK104099A3 (en) 2000-01-18
BR9807181A (pt) 2000-01-25
CZ279299A3 (cs) 1999-11-17
IL131127A0 (en) 2001-01-28
BG103631A (en) 2000-11-30

Similar Documents

Publication Publication Date Title
YU28797A (sh) Heterociklicno kondenzovani piridini
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
YU28897A (sh) Biciklicno kondenzovani piridini
ATE269850T1 (de) 3-thiocarbamoylpyrazol-derivate als pestiziden
ATE228111T1 (de) M-amidinophenyl-analoga als faktor-xa-inhibitoren
DE69720811D1 (de) L-Ribavirin und dessen Verwendung
ATE260910T1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep)
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
PT813525E (pt) Derivados de benzamidina e sua utilizacao como anticoagulantes
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
MX9804597A (es) Derivados de bencimidazol sustituidos por naftilo como anticoagulantes.
DK0741710T3 (da) Chlorpyrimidin-mellemprodukter
NO983003L (no) Vitronectin-reseptor-antagonister
EP0735819A4 (en) NEW CRYPTOPHYCINE
DE60140516D1 (de) Behandlung von fluorkohlenstoff- ausgangsmaterialien
ATE285221T1 (de) Orale zusammensetzung mit verbessertem bleichendem effekt
BRPI0415773A (pt) derivados de indolinona e sua aplicação no tratamento de estados de doença tais como cáncer
DE69232585D1 (de) Oligosidderivat aus einem polyosidantigen von einem pathogenen erreger
DE69719778D1 (de) Benzonaphthyridine als bronchialtherapeutika
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
NO993738L (no) 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi
BG101109A (bg) Пиридилтио-съединения,метод за получаването им иприложението им за борба с бактерии от рода хеликобактер
DE60029954D1 (de) Dermale anästhetika
ATE451103T1 (de) Zusammensetzung zur behandlung von atherosklerose,die candesartan und rosuvastatin enthält